To celebrate Innovation and Excellence in the Pharmaceuticals and life Sciences sector Cadila Pharmaceuticals limited –– organised scientific conclave– Indravadan Ambalal Modi Innovation Conclave (IAMICON)-2014 in Dehradun. Covering 50 cities across India, IAMICON- 2014 focused on advance treatment of Tuberculosis and Cardiovascular diseases.
This year, Dr Mohamad Akram (MD Medicine), Gold Medalist from Jolly Grant Medical College was conferred the ‘IAMICON-2014’ by chief guest Dr P Jaithani. Dr Kuldeep Dutta and Dr KJS Sabharwal were chairpersons for the sessions on ‘Cardiovascular Risk Management’ and ‘Recent Advancements in Tuberculosis’, respectively.
Dr Rajiv Modi, chairman and managing director, Cadila Pharmaceuticals ltd. said, “India’s pharmaceuticals sector has creditable contribution in providing affordable medicines to patients in India and across the globe. There have been bright sparks of innovation in our country, which have not received due attention. By showcasing such efforts every year and promoting the spirit of Indian innovation, IAMICON seeks to pay eternal tribute to our Founder-Chairman Indravadan Ambalal Modi, the legendary Medicine Man of India.
In his perennial quest for making medicines affordable to the last man in the society, he accorded highest importance to research and innovation. He put in path-breaking efforts to have process patents recognised and his initiatives culminated in the amended Indian Patents Act, 1970, which recognized process patents and helped pioneer India’s generics industry.”